{"id":21974,"date":"2025-11-18T19:57:52","date_gmt":"2025-11-18T18:57:52","guid":{"rendered":"https:\/\/europa-peptide.com\/?post_type=product&p=21974"},"modified":"2026-05-21T22:52:08","modified_gmt":"2026-05-21T20:52:08","slug":"semaglutide-ozempic","status":"publish","type":"product","link":"https:\/\/europa-peptide.com\/nl\/shop\/semaglutide-ozempic\/","title":{"rendered":"Semaglutide"},"content":{"rendered":"

Semaglutide - GLP-1 receptoragonist voor metabolisme- en gewichtscontrole<\/strong><\/p>\n

Samenstelling: <\/strong>Semaglutide (gevriesdroogd peptidepoeder)
Categorie:<\/strong> Peptide
Vorm:<\/strong> Flacon met gevriesdroogd poeder
Administratie:<\/strong> Subcutane injectie na reconstitutie met bacteriostatisch water<\/p>\n

\n

Wat is Semaglutide?<\/h3>\n

Semaglutide<\/strong> is een langwerkende GLP-1 (Glucagon-Like Peptide-1)-receptoragonist<\/strong> dat de werking van het natuurlijke incretinehormoon GLP-1 nabootst.
Het werkt door insulinesecretie verhogen<\/strong>, verminderen van glucagonafgifte<\/strong>, maaglediging vertragen<\/strong>, en verzadiging bevorderen<\/strong>, waardoor het een van de toonaangevende verbindingen in onderzoek naar stofwisseling en obesitas.<\/strong><\/p>\n

In preklinische en klinische studies heeft Semaglutide aangetoond een sterk potentieel te hebben voor verbetering van het glucosemetabolisme<\/strong>, lichaamsgewicht verminderen<\/strong>, en cardiometabolische gezondheid optimaliseren.<\/strong><\/p>\n

\u27a1\ufe0f Ideaal voor energiebalans, eetlustregulatie,<\/strong> en glucoseregeling.<\/strong><\/p>\n

\n

Belangrijkste onderzoeksresultaten<\/h3>\n

Eetlust onder controle:<\/strong> Activeert GLP-1 receptoren in de hersenen om honger verminderen<\/strong> en vroege verzadiging bevorderen.<\/strong><\/p>\n

Gewichtsbeheersing:<\/strong> Onderzoeken toonden aan dat lichaamsvet aanzienlijk verminderen<\/strong> en verbeteren lichaamssamenstelling.<\/strong><\/p>\n

Bloedsuikerregulatie:<\/strong> Verbetert insulinegevoeligheid<\/strong> en stabiliseert glucoseniveaus.<\/strong><\/p>\n

Cardiometabolische gezondheid:<\/strong> Kan verbeteren lipidenprofielen<\/strong> en vetmetabolisme<\/strong> terwijl het verminderen van oxidatieve stress.<\/strong><\/p>\n

Langwerkend effect:<\/strong> Vanwege de verlengde halfwaardetijd<\/strong>, eenmaal per week doseren<\/strong> is mogelijk in onderzoekssettings.<\/p>\n

\n

Dosering en toepassing<\/h3>\n

Reconstitueer met bacteriostatisch water<\/strong> voor gebruik.<\/p>\n

Typisch onderzoeksbereik: 0,25-1,0 mg per toepassing<\/strong>, subcutaan, 1-2 keer per week<\/strong> (afhankelijk van de onderzoeksopzet).<\/p>\n

Bewaar de gereconstitueerde oplossing gekoeld<\/strong> en gebruik binnen 30 dagen.<\/strong><\/p>\n

\n

Instructies voor opslag<\/h3>\n
    \n
  • \n

    Opslaan bij 2-8 \u00b0C (36-46 \u00b0F)<\/strong><\/p>\n<\/li>\n

  • \n

    Beschermen tegen licht en vocht<\/strong><\/p>\n<\/li>\n

  • \n

    Niet invriezen<\/strong><\/p>\n<\/li>\n

  • \n

    Temperatuurschommelingen vermijden<\/p>\n<\/li>\n<\/ul>\n

    \n

    Waarom kiezen voor Semaglutide?<\/h3>\n

    Semaglutide<\/strong> is een van de meest onderzochte GLP-1-analogen<\/strong> wereldwijd, bekend om zijn dubbelfunctie<\/strong> in gewicht en bloedsuikerregulatie.<\/strong>
    Zijn langdurige werking<\/strong>, gunstig metabolisch profiel<\/strong>, en breed scala aan onderzoekstoepassingen<\/strong> maak er een hoeksteen samenstelling<\/strong> in metabole en endocriene wetenschap.<\/strong><\/p>\n

    Semaglutide bestellen <\/strong>en het potentieel ervan te onderzoeken in geavanceerd onderzoek naar stofwisseling en gewichtsbeheersing.<\/strong><\/p>","protected":false},"excerpt":{"rendered":"

    Semaglutide \u2013 GLP-1 Receptor Agonist for Metabolic & Weight Management Composition: Semaglutide (lyophilized peptide powder)Category: PeptideForm: Vial with freeze-dried powderAdministration: Subcutaneous injection after reconstitution with bacteriostatic water What is Semaglutide? Semaglutide is a long-acting GLP-1 (Glucagon-Like Peptide-1) receptor agonist that mimics the action of the natural incretin hormone GLP-1.It works by enhancing insulin secretion, reducing glucagon release, slowing gastric emptying, and promoting satiety, making it one of the leading compounds in metabolic and obesity research. In preclinical and clinical studies, Semaglutide has demonstrated strong potential for improving glucose metabolism, reducing body weight, and optimizing cardiometabolic health. \u27a1\ufe0f Ideal for energy balance, appetite regulation, and glucose control. Key Research Findings Appetite Control: Activates GLP-1 receptors in the brain to reduce hunger and promote early satiety. Weight Management: Shown in studies to significantly reduce body fat and improve body composition. Blood Sugar Regulation: Enhances insulin sensitivity and stabilizes glucose levels. Cardiometabolic Health: May improve lipid profiles and fat metabolism while reducing oxidative stress. Long-Acting Effect: Due to its extended half-life, once-weekly dosing is possible in research settings. Dosage & Application Reconstitute with bacteriostatic water before use. Typical research range: 0.25\u20131.0 mg per application, subcutaneously, 1\u20132 times per week (depending on study design). Store the reconstituted solution refrigerated and use within 30 days. Storage Instructions Store at 2\u20138 \u00b0C (36\u201346 \u00b0F) Protect from light and moisture Do not freeze Avoid temperature fluctuations Why Choose Semaglutide? Semaglutide is among the most extensively studied GLP-1 analogues worldwide, known for its dual function in weight and blood sugar regulation.Its long-lasting action, favorable metabolic profile, and broad range of research applications make it a cornerstone compound in metabolic and endocrine science. Order Semaglutide and explore its potential in advanced metabolic and weight management research.<\/p>","protected":false},"featured_media":67,"comment_status":"open","ping_status":"closed","template":"","meta":{"_acf_changed":false},"product_brand":[],"product_cat":[17,24,25,27],"product_tag":[],"class_list":["post-21974","product","type-product","status-publish","has-post-thumbnail","product_cat-all-products","product_cat-glp-1andmultiagonist","product_cat-metabolismandweightmanagement","product_cat-peptidesandresearchdrugs","entry","has-media","first","instock","shipping-taxable","purchasable","product-type-variable"],"acf":[],"aioseo_notices":[],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/europa-peptide.com\/nl\/wp-json\/wp\/v2\/product\/21974","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/europa-peptide.com\/nl\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/europa-peptide.com\/nl\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/europa-peptide.com\/nl\/wp-json\/wp\/v2\/comments?post=21974"}],"version-history":[{"count":3,"href":"https:\/\/europa-peptide.com\/nl\/wp-json\/wp\/v2\/product\/21974\/revisions"}],"predecessor-version":[{"id":28948,"href":"https:\/\/europa-peptide.com\/nl\/wp-json\/wp\/v2\/product\/21974\/revisions\/28948"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/europa-peptide.com\/nl\/wp-json\/wp\/v2\/media\/67"}],"wp:attachment":[{"href":"https:\/\/europa-peptide.com\/nl\/wp-json\/wp\/v2\/media?parent=21974"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/europa-peptide.com\/nl\/wp-json\/wp\/v2\/product_brand?post=21974"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/europa-peptide.com\/nl\/wp-json\/wp\/v2\/product_cat?post=21974"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/europa-peptide.com\/nl\/wp-json\/wp\/v2\/product_tag?post=21974"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}